Meet founding CEOs of academic start-ups and pre-seed companies in our poster session, the Pipeline Cafe.
Pipeline Café Participants
Darnisha Harrison, Founder & CEO, Ennaid Therapeutics – Using Flavivirus Peptide Inhibitors To Treat All Four Strains of Dengue Virus
Gerard Honig, PhD, Founder & Chief Executive Officer, Symbiotic Health, Inc. – Effectiveness of a microbiome-based capsule therapeutic for the treatment of recurrent C. difficile infection
Jingfang Ju, Ph.D, Co-Director of Translational Research Laboratory, Department of Pathology, Stony Brook University – Overcome Chemoresistance via miRNA in Colorectal Cancer
Sanjoy K. Mahanty, PhD, Chief Executive Officer, MirCan Therapeutics, LLC – Development of miR-708, a unique regulatory micro RNA molecule for the treatment of metastatic breast cancer including triple negative breast cancer (TNBC)
Maria Pineda, PhD, CEO and Martin Akerman, PhD, CSO, Envisagenics – The SpliceCoreTM platform: Uncovering hidden patterns in biological data to advance drug-development
Mark Punyanitya, Co-Founder, MagnePath USA – Improving Quantitative Imaging for Obesity, Diabetes, and Liver Disease
John P. Wilson, PhD, Chief Executive Officer, Banish Technologies™
Banish Technologies™: eliminate bacteria reservoir biohazards
Nader Yaghoubi, MD, PhD, President and Chief Executive Officer, PathMaker NeuroSystems Inc.- Non-Invasive Neuromodulation using trans-spinal Direct Current Stimulation (tsDCS) for the treatment of Paralysis and Muscle Disorders
Weng-Lang Yang, PhD, Chief Scientific Officer, Therasource – Recombinant Human MFG-E8 Protein for Treating Inflammatory Diseases
Ehsan Yazdi, PhD, Chief Executive Officer, NomoCan Pharmaceuticals LLC – A Novel Drug for Diagnosis and Treatment of Pancreatic Cancer
